Selective inhibition of guanylate cyclase prevents impairment of hypoxic pulmonary vasoconstriction in endotoxemic mice

Journal of Physiology and Pharmacology

Volumn 60, Issue 2, 2009, Pages 107-112

  Spohr, F ^a   Busch, C J ^b   Teschendorf, P ^a   Weimann, Jorg ^c,d  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Sankt Gertrauden Hospital   (Germany)

Author keywords

Cyclic GMP; Endotoxemia; Guanylate cyclase; Lung; Mice; Nitric oxide; Vasoconstriction

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLIC GMP; GUANYLATE CYCLASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; HYPOXIC LUNG VASOCONSTRICTION; ISOLATED LUNG; LUNG ARTERY PRESSURE; LUNG VASOCONSTRICTION; MALE; MOUSE; NONHUMAN; PERFUSION PRESSURE;

ANIMALS; ANOXIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXEMIA; GUANYLATE CYCLASE; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED C57BL; OXADIAZOLES; PULMONARY CIRCULATION; QUINOXALINES; VASOCONSTRICTION;

EID: 68049093983     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Astiz ME, Rackow EC. Septic shock. Lancet 1998; 351: 1501-1505.
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
3. Mehta S. The effects of nitric oxide in acute lung injury. Vascul Pharmacol 2005; 43: 390-403. (Pubitemid 41654720)
4. Spohr F, Cornelissen AJ, Busch C et al. Role of endogenous nitric oxide in endotoxin-induced alteration of hypoxic pulmonary vasoconstriction in mice. Am J Physiol Heart Circ Physiol 2005; 289: H823-H831. (Pubitemid 41129400)
5. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
6. Lincoln TM, Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J 1993; 7: 328-338. (Pubitemid 23067783)
7. Moro MA, Russel RJ, Cellek S et al. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA 1996; 93: 1480-1485. (Pubitemid 26075149)
8. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994; 368: 850-853. (Pubitemid 24137748)
9. Wei EP, Kontos HA, Beckman JS. Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite. Am J Physiol 1996; 271: H1262-H1266. (Pubitemid 126832347)
10. Landino LM, Crews BC, Timmons MD, Morrow JD, Marnett LJ. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci USA 1996; 93: 15069-15074.
11. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxidesensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol 1995; 48: 184-188.
12. Fernandes D, da Silva-Santos JE, Duma D, Villela CG, Barja-Fidalgo C, Assreuy J. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity. Mol Pharmacol 2006; 69: 983-990.
13. Zingarelli B, Hasko G, Salzman AL, Szabo C. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock. Crit Care Med 1999; 27: 1701-1707. (Pubitemid 29455092)
14. Weimann J, Bloch KD, Takata M, Steudel W, Zapol WM. Congenital NOS2 deficiency protects mice from LPS-induced hyporesponsiveness to inhaled nitric oxide. Anesthesiology 1999; 91: 1744-1753.
15. Linehan JH, Haworth ST, Nelin LD, Krenz GS, Dawson CA. A simple distensible vessel model for interpreting pulmonary vascular pressure-flow curves. J Appl Physiol 1992; 73: 987-994.
16. Ullrich R, Bloch KD, Ichinose F, Steudel W, Zapol WM. Hypoxic pulmonary blood flow redistribution and arterial oxygenation in endotoxin-challenged NOS2-deficient mice. J Clin Invest 1999; 104: 1421-1429.
17. Ichinose F, Ullrich R, Sapirstein A et al. Cytosolic phospholipase A(2) in hypoxic pulmonary vasoconstriction. J Clin Invest 2002; 109: 1493-1500. (Pubitemid 34596175)
18. Leeman M, de Beyl VZ, Biarent D, Maggiorini M, Melot C, Naeije R. Inhibition of cyclooxygenase and nitric oxide synthase in hypoxic vasoconstriction and oleic acid-induced lung injury. Am J Respir Crit Care Med 1999; 159: 1383-1390. (Pubitemid 29227842)
19. Uzun O, Demiryurek AT. Role of NO and prostaglandins in acute hypoxic vasoconstriction in sheep pulmonary veins. Pharmacology 2006; 77: 122-129. (Pubitemid 44114388)
20. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 1557-1558.
21. Gebska A, Olszanecki R, Korbut R. Endotoxaemia in rats: role of leukocyte sequestration in rapid pulmonary nitric oxide synthase-2 expression. J Physiol Pharmacol 2005; 56: 299-311. (Pubitemid 40911095)
22. Kristof AS, Goldberg P, Laubach V, Hussain SN. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1998; 158: 1883-1889. (Pubitemid 29008829)
23. Sprague RS, Stephenson AH, Dimmitt RA et al. Effect of LNAME on pressure-flow relationships in isolated rabbit lungs: role of red blood cells. Am J Physiol 1995; 269: H1941-H1948.
24. Uncles DR, Daugherty MO, Frank DU, Roos CM, Rich GF. Nitric oxide modulation of pulmonary vascular resistance is red blood cell dependent in isolated rat lungs. Anesth Analg 1996; 83: 1212-1217.
25. Weissmann N, Akkayagil E, Quanz K et al. Basic features of hypoxic pulmonary vasoconstriction in mice. Respir Physiol Neurobiol 2004 ;139: 191-202. (Pubitemid 38281122)
26. Weissmann N, Voswinckel R, Tadic A et al. Nitric oxide (NO)-dependent but not NO-independent guanylate cyclase activation attenuates hypoxic vasoconstriction in rabbit lungs. Am J Respir Cell Mol Biol 2000; 23: 222-227. (Pubitemid 30656432)
27. Fouty B, Komalavilas P, Muramatsu M et al. Protein kinase G is not essential to NO-cGMP modulation of basal tone in rat pulmonary circulation. Am J Physiol 1998; 274: H672-H678. (Pubitemid 28103001)
28. Gupte SA, Okada T, McMurtry IF, Oka M. Role of pentose phosphate pathway-derived NADPH in hypoxic pulmonary vasoconstriction. Pulm Pharmacol Ther 2006; 19: 303-309.
29. da Silva-Santos JE, Terluk MR, Assreuy J. Differential involvement of guanylate cyclase and potassium channels in nitric oxide-induced hyporesponsiveness to phenylephrine in endotoxemic rats. Shock 2002; 17: 70-76.
30. Spohr F, Busch CJ, Reich C et al. 4-Aminopyridine restores impaired hypoxic pulmonary vasoconstriction in endotoxemic mice. Anesthesiology 2007; 107: 597-604. (Pubitemid 47480566)
31. Zacharowski K, Berkels R, Olbrich A et al. The selective guanylate cyclase inhibitor ODQ reduces multiple organ injury in rodent models of Gram-positive and Gram-negative shock. Crit Care Med 2001; 29: 1599-1608. (Pubitemid 32762343)
32. Carter EP, Sato K, Morio Y, McMurtry IF. Inhibition of K(Ca) channels restores blunted hypoxic pulmonary vasoconstriction in rats with cirrhosis. Am J Physiol Lung Cell Mol Physiol 2000; 279: L903-L910. (Pubitemid 30952009)
33. Glynos C, Kotanidou A, Orfanos SE et al. Soluble guanylyl cyclase expression is reduced in LPS-induced lung injury. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1448-R1455. (Pubitemid 46557804)
34. Andresen M, Dougnac A, Diaz O et al. Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange. J Crit Care 1998; 13: 164-168. (Pubitemid 29015271)
35. Gachot B, Bedos JP, Veber B, Wolff M, Regnier B. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock. Intensive Care Med 1995; 21: 1027-1031. (Pubitemid 26009318)
36. Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 1993; 45: 367-374. (Pubitemid 23042635)
37. Keaney JF Jr., Puyana JC, Francis S, Loscalzo JF, Stamler JS, Loscalzo J. Methylene blue reverses endotoxin-induced hypotension. Circ Res 1994; 74: 1121-1125. (Pubitemid 24176906)
38. Marczin N, Tekeres M, Salzman AL, Szabo C. Methylene blue infusion in septic shock. Crit Care Med 1995; 23 :1936-1938.